Concepedia

Mark A. Ator

MA

77

Publications

4.1K

Citations

42

H-Index

1983

Active since

Affiliations

Brandywine Photonics (United States)(Current)

Teva Pharmaceuticals (United States)

South College

Sterling Research Group

University of California, San Francisco

Mark A. Ator is an author at Brandywine Photonics (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1983–2023

77

Publications

77

Protein control of prosthetic heme reactivity. Reaction of substrates with the heme edge of horseradish peroxidase.

Mark A. Ator, P.R. Ortiz de Montellano · Journal of Biological Chemistry · 1987 · 218 citations · Full text

P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme

Roland E. Dolle, C. V. C. Prasad, Stanley J. Schmidt et al. · Journal of Medicinal Chemistry · 1994 · 146 citations

, , +18

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee et al. · Journal of Medicinal Chemistry · 2008 · 146 citations · Full text

Mechanism-based inactivation of horseradish peroxidase by sodium azide. Formation of meso-azidoprotoporphyrin IX

Paul R. Ortiz de Montellano, Shantha David, Mark A. Ator et al. · Biochemistry · 1988 · 142 citations

Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

Joel Kaye, Victor Piryatinsky, Tal Birnberg et al. · Proceedings of the National Academy of Sciences · 2016 · 133 citations · Full text

Rows per page

1–5 of 77